A tie-up with LaNova was terminated, perhaps in favour of a molecule originated by I-Mab.
ApexOnco Front Page
Recent articles
17 October 2024
The French group takes a shot at Perspective with its second bet on Orano Med.
16 October 2024
Jazz's somewhat low-key SCLC drug scores its biggest win yet.
16 October 2024
The Hutchmed-originated savolitinib moves towards its first US approval.
15 October 2024
OncoC4’s AI-081 features among the industry’s latest first-in-human trial initiations.
11 October 2024
The company reckons it can outdo Bristol’s relatlimab in first-line NSCLC.
9 October 2024
The group will present the first clinical data on its KRAS G12D-selective project RMC-9805.
Recent Quick take
- 22 October 2024
- 21 October 2024
- 21 October 2024
- 18 October 2024
- 18 October 2024
- 18 October 2024
- 16 October 2024
- 15 October 2024
- 14 October 2024
- 14 October 2024